Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection

Transplantation

Volumn 65, Issue 11, 1998, Pages 1436-1446

  McKisic, Maureen D ^a   Macy Jr , James D ^b   Delano, Margaret L ^c   Jacoby, Robert O ^b   Paturzo, Frank X ^b   Smith, Abigail L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; GENE DISRUPTION; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TISSUE CULTURE; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; CELL DIVISION; DNA, VIRAL; GRAFT REJECTION; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PARVOVIRIDAE INFECTIONS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; VIRION;

EID: 0032526064     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00005     Document Type: Article

References (68)

1. Smith DM, Stuart FP, Wemhoff GA, Quintans J, Fitch FW. Cellular pathways for rejection of class-I-MHC-disparate skin and tumor allografts. Transplantation 1988; 45: 168.
2. McKisic MD, Paturzo FX, Smith AL. Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation 1996; 61: 292.
3. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 1987; 33: 91.
4. Anderson LJ. Human parvoviruses. J Infect Dis 1990; 161: 603.
5. Tattersall P, Cotmore SF. The rodent parvoviruses. In: Bhatt PN, Jacoby RO, Morse HC, III, New AE, eds. Viral and mycoplasmal infections of laboratory rodents: effects on biomedical research. Orlando, FL: Academic Press, 1986: 305.
6. Berns KI. Parvovirus replication. Microbiol Rev 1990; 54: 316.
7. Smith AL, Jacoby RO, Johnson EA, Paturzo F, Bhatt PN. In vivo studies with an "orphan" parvovirus of mice. Lab Anim Sci 1993; 43: 175.
8. Jacoby RO, Johnson EA, Ball-Goodrich L, Smith AL, McKisic MD. Characterization of mouse parvovirus infection by in situ hybridization. J Virol 1995; 69: 3915.
9. McKisic MD, Lancki DW, Otto G, et al. Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol 1993; 150: 419.
10. Ball-Goodrich LJ, Johnson E. Molecular characterization of a newly recognized mouse parvovirus. J Virol 1994; 68: 6476.
11. Bonnard GD, Manders EK, Campbell DA Jr, Herberman RB, Collins MJ Jr. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma: evidence for minute virus of mice causing the inhibition. J Exp Med 1976; 143: 187.
12. Engers HD, Louis JA, Zubler RH, Hirt B. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J Immunol 1981; 127: 2280.
13. Guetta E, Graziani Y, Tal J Suppression of Ehrlich ascites tumor in mice by minute virus of mice. J Natl Cancer Inst 1986; 76: 1177.
14. Kimsey PB, Engers HD, Hirt B, Jongeneel CV. Pathogenicity of fibroblast- and lymphocyte-specific variants of minute virus of mice. J Virol 1986; 59: 8.
15. Torok TJ. Parvovirus B19 and human disease. Adv Intern Med 1992; 37: 431.
16. Vigeant P, Menard H-A, Boire G. Chronic modulation of the autoimmune response following parvovirus B19 infection. J Rheumatol 1994; 21: 1165.
17. Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990; 33: 1297.
18. Cope AP, Jones A, Brozovic M, Shafi MS, Maini RN. Possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis 1992; 51: 803.
19. Frickhofen N, Young NS. Persistent parvovirus B19 infections in humans. Microbial Pathogenesis 1989; 7: 319.
20. Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rhematol Int 1992; 12: 147.
21. db: a new mutant in BALB/cKh that identifies a locus associated with the D region. Immunogenetics 1977; 4: 333.
22. Smith AL. Response of weanling random-bred mice to inoculation of minute virus of mice. Lab Anim Sci 1983; 33: 37.
23. Glasebrook AL, Sarmiento M, Loken MR, et al. Murine T lymphocyte clones with distinct immunological functions. Immunol Rev 1981; 54: 225.
24. Glasebrook AL, Fitch FW. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med 1980; 151: 876.
25. + T-lymphocyte subset. Tranplant Proc 1989; 21: 162.
26. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule, designated L3T4 identified by monoclonal antibody GK1.5: similarity to human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
27. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
28. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077.
29. Jacoby RO, Bhatt PN, Jonas AM. Viral diseases. In: Baker HJ, Lindsey JR, Weisbroth SH, eds. The laboratory rat: biology and diseases. New York: Academic Press, 1979: 272.
30. Urban JL, Schreiber H. Tumor antigens. Annu Rev Immunol 1992; 10: 617.
31. Tevethia S, Flyer D, Tijian R. Biology of SV40 transplantation antigen. VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T-antigen (D2 protein). Virology 1980; 107: 13.
32. Frazer IH. Immunology of papillomavirus infection. Curr Opin Immunol 1996; 8: 484.
33. Tindle RW. Human papillomavirus vaccines for cervical cancer. Curr Opin Immunol 1996; 8: 643.
34. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens mechanisms of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745.
35. Webb SR, Gascoigne NR. T-cell activation by superantigens. Curr Opin Immunol 1994; 6: 467.
36. Acha-Orbea H, Palmer E. Mls-a retrovirus exploits the immune system. Immunol Today 1991; 12: 356.
37. Simpson E. Non-H-2 histocompatibility antigens: can they be retroviral products? Immunol Today 1987; 8: 176.
38. Breyere EJ, Williams LB. Antigens associated with a tumor virus: rejection of isogenic skin grafts from leukemic mice. Science 1964; 146: 1055.
39. Meeker WR Jr, Grace JT Jr. Rejection of skin isografts from donors with leukemia. Surg Forum 1968; 19: 89.
40. Mariani T, Dent PB, Good RA. Alteration of skin in gross leukemia. I. Syngeneic skin-graft rejection and tumor development. J Natl Cancer Inst 1970; 49: 879.
41. Svet-Moldavsky GJ, Mkheidze DM, Liozner AL. Skin heterogenizing virus. Nature 1968; 217: 102.
42. Eichwald EJ, Rud B. "Heterogenization" of mouse skin. Transplant 1968; 6: 618.
43. Holtermann OA, Majde JA. Rejection of skin grafts from mice chronically infected with lymphocytic choriomeningitis virus by noninfected syngeneic recipients. Nature 1969; 223: 624.
44. Salaman MH, Turk JL, Wedderburn N. Foreign antigenicity in tissue of mice infected with a lymphomagenic virus. Transplant 1973; 16: 583.
45. Martz E, Howell DM. CTL: virus control cells first and cytolytic cells second? Immunol Today 1989; 10: 79.
46. Doherty PC, Allan W, Eichelberger M. Role of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 1992; 10: 123.
47. Mamula MJ, Craft JJ. The expression of self antigenic determinants: implications for tolerance and autoimmunity. Curr Opin Immunol 1994; 6: 882.
48. Elson CJ, Barker RN, Thompson SJ, Williams NA. Immunologically ignorant autoreactive T cells, epitope spreading, and repertoire limitation. Immunol Today 1995; 16: 71.
49. Mamula MJ. The inability to process a self-peptide allows auto-reactive T cells to escape tolerance. J Exp Med 1993; 177: 567.
50. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319.
51. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993; 14: 203.
52. Bluestone JA. New perspectives on CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555.
53. Rossman MD, Maida BT, Douglas SD. Monocyte-derived macrophage and alveolar macrophage fibronectin production and cathepsin D activity. Cell Immunol 1990; 126: 268.
54. Yang Y, Waters JB, Fruh K, Peterson PA. Proteasomes are regulated by interferon gamma: implications for antigen processing. Proc Natl Acad Sci USA 1992; 89: 4928.
55. Frosch S, Bonifas U, Eck H-P, et al. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular thiols. Eur J Immunol 1993; 23: 1430.
56. O'Garra A, Murphy K. T cell subsets in autoimmunity. Curr Opin Immunol 1993; 5: 880.
57. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune disease. Immunol Today 1995; 16: 383.
58. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34.
59. Ohashi PS, Obhen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305.
60. Vidard L, Rock KL, Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells: effect of cell culture on antigen processing ability. J Immunol 1992; 149: 1905.
61. Oldstone MBA. Viral persistence. Cell 1989; 56: 517.
62. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994; 76: 323.
63. Maudsley DJ, Pound JD. Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 1991; 12: 429.
64. Rinaldo CR Jr. Modulation of major histocompatibility complex antigen expression by viral infection. Am J Pathol 1994; 144: 637.
65. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993; 11: 29.
66. Jawad ASM. Persistent arthritis after human parvovirus B19 infection. Lancet 1993; 341: 494.
67. Kandolf R, Dirschner O, Hofschneider PH, Vischer TL. Detection of parvovirus in a patient with reactive arthritis by in situ hybridization. Clin Rhematol 1989; 8: 398.
68. Mayo DR, Vance DW Jr. Parvovirus B19 as the cause of a syndrome resenbling Lyme arthritis in adults. N Engl J Med 1991; 324: 419.